JAMDA
Volume 9, Issue 1 , Pages 51-54, January 2008

Prevalence of a Hemoglobin A1c Less Than 7.0%, of a Blood Pressure Less Than 130/80 mm Hg, and of a Serum Low-Density Lipoprotein Cholesterol Less Than 100 mg/dL in Older Patients With Diabetes Mellitus in an Academic Nursing Home

Department of Medicine, Divisions of Geriatrics and Cardiology, New York Medical College, Valhalla, NY.

published online 13 December 2007.

Objective

To determine the prevalence of a hemoglobin A1c less than 7.0%, of a blood pressure less than 130/80 mm Hg, and of a serum low-density lipoprotein (LDL) cholesterol less than 100 mg/dL in older persons with diabetes mellitus who were not terminally ill in an academic nursing home.

Design

We investigated in all older diabetic individuals who were not terminally ill in an academic nursing home the prevalence of a hemoglobin A1c less than 7.0%, of a blood pressure less than 130/80 mm Hg, and of a serum LDL cholesterol less than 100 mg/dL.

Setting

An academic nursing home.

Participants

Of 202 persons, 62 (31%) had diabetes mellitus. The 62 diabetic individuals included 33 women and 29 men, mean age 73 ± 9 years.

Measurements

Prevalence of hemoglobin A1c less than 7.0%, of blood pressure less than 130/80 mm Hg, and of serum LDL cholesterol less than 100 mg/dL.

Results

The hemoglobin A1c was less than 7.0% in 55 (89%) of 62 diabetic individuals. The blood pressure was less than 130/80 mm Hg in 52 (84%) of 62 diabetic individuals. The serum LDL cholesterol was less than 100 mg/dL in 55 (89%) of 62 diabetic individuals.

Conclusion

As recommended by the American Diabetes Association, the hemoglobin A1c was less than 7.0% in 55 (89%) of 62 diabetic individuals, the blood pressure was less than 130/80 mm Hg in 52 (84%) of 62 diabetic individuals, and the serum LDL cholesterol was less than 100 mg/dL in 55 (89%) of 62 diabetic individuals in an academic nursing home.

Keywords: Diabetes mellitus, hemoglobin A1c, blood pressure, low-density lipoprotein cholesterol, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, statins, renal insufficiency

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 None of the authors have any conflicts of interest pertaining to this study.

PII: S1525-8610(07)00393-3

doi:10.1016/j.jamda.2007.08.012

JAMDA
Volume 9, Issue 1 , Pages 51-54, January 2008